NL-OMON20950
Recruiting
Not Applicable
Development of Arthritis in Psoriasis Patients for Early Rheumatological referral – Incidence
Investigator-initiated0 sites250 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Investigator-initiated
- Enrollment
- 250
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\* Diagnosis of cutaneous psoriasis
- •\* Inclusion in DAPPER study
- •\* Age 16 years or above
- •\* Willing and able to comply with visits and study\-related procedures
- •\* Provide signed informed consent (IC)
Exclusion Criteria
- •\* Medical history with PsA
- •\* Medical history with other immune\-mediated or auto\-immune rheumatological disease. For example, but not limited to: rheumatoid arthritis, systemic vasculitis, axial spondyloarthritis. Gout, fibromyalgia or osteo\-arthritis are not excluded.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Gewrichtsontstekingen bij patiënten met psoriasisNL-OMON21407Radboudumc300
Completed
Not Applicable
Discovery of Arthritis in Psoriasis Patients for Early Rheumatological referral (DAPPERpsoriasispsoriatic arthritis1002321310014982NL-OMON48399Radboud Universitair Medisch Centrum300
Unknown
Not Applicable
Frequency of arthritis in patients of psoriasisHealth Condition 1: L405- Arthropathic psoriasisCTRI/2020/02/023523Maulana Azad Medical College
Withdrawn
Phase 4
Prevalence of Psoriatic Arthritis in Adults with Psoriasis: An Estimate From Dermatology PracticePsoriasisPsoriatic arthritis1002321310014982NL-OMON34134Pfizer20
Active, not recruiting
Not Applicable
Investigation of the molecular size distribution of hyaluronan and the effect of adalimumab treatment of psoriatic arthritis.EUCTR2012-004940-31-SEDept of medical sciences, Rheumatology